RIVERVIEW MEDICAL CENTER
1. Target Overview & Investment Thesis
RIVERVIEW MEDICAL CENTER is a 267-bed suburban community hospital in MONMOUTH, NJ with $365.4M in net patient revenue and a 5.6% operating margin. The hospital serves a payer mix of 38.9% Medicare, 3.9% Medicaid, and 57.2% commercial.
Thesis: Platform Growth. Our ML models identify $26.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.6% to 12.9% (+736bps).
| Net Revenue HCRIS | $365.4M |
| Current EBITDA COMPUTED | $20.3M |
| Operating Margin COMPUTED | 5.6% |
| Occupancy HCRIS | 53.9% |
| Revenue / Bed COMPUTED | $1.4M |
| Net-to-Gross HCRIS | 25.0% |
| Distress Probability ML | 47.4% |
2. Market Context & Competitive Position
NJ has 95 Medicare-certified hospitals with a median operating margin of -3.9%. The target's margin of 5.6% places it above the state median. Among 50 size-comparable peers (134-534 beds), the median margin is -6.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (134-534), prioritizing same-state peers. 50 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| RIVERVIEW MEDICAL CENTER (Target) | NJ | 267 | $365.4M | 5.6% |
| ENGLEWOOD HOSPITAL & MED CTR | NJ | 292 | $967.3M | 0.1% |
| THE VALLEY HOSPITAL | NJ | 385 | $951.8M | 17.5% |
| OVERLOOK MEDICAL CENTER | NJ | 440 | $880.2M | 8.9% |
| ATLANTICARE REGIONAL MEDICAL C | NJ | 532 | $791.4M | 2.3% |
| CAPITAL HEALTH MED CENTER - HO | NJ | 209 | $746.8M | 0.8% |
| UH - UNIVERSITY HOSPITAL | NJ | 358 | $702.0M | -27.5% |
| JFK UNIVERSITY MEDICAL CENTER | NJ | 351 | $688.7M | -6.8% |
| NEWARK BETH ISRAEL MEDICAL CEN | NJ | 422 | $669.9M | -9.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $26.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $7.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $7.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $7.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $4.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $234K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $20.3M |
| + RCM Uplift | +$26.9M |
| Pro Forma EBITDA | $47.2M |
| Current Margin | 5.6% |
| Pro Forma Margin | 12.9% |
| WC Released (1x) | $14.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $31.2M | $402.8M | 12.90x | 66.8% |
| Base (11x exit) | 10.0x | 11.0x | $31.2M | $453.3M | 14.52x | 70.8% |
| Bull Case | 9.0x | 11.0x | $28.1M | $552.2M | 19.65x | 81.4% |
| Bull (12x exit) | 9.0x | 12.0x | $28.1M | $610.7M | 21.74x | 85.1% |
| Bear Case | 11.0x | 10.0x | $34.3M | $258.2M | 7.52x | 49.7% |
| Bear (11x exit) | 11.0x | 11.0x | $34.3M | $295.2M | 8.60x | 53.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 50 hospitals with 134-534 beds
- Same-state prioritization (n=51)
- Comp margins: P25=-17.4% / P50=-6.8% / P75=2.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.